Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.79M Buy
26,626
+1,059
+4% +$235K 0.47% 33
2025
Q4
$5.84M Buy
25,567
+130
+0.5% +$29.6K 0.48% 31
2025
Q3
$5.89M Buy
25,437
+554
+2% +$113K 0.49% 33
2025
Q2
$4.62M Buy
24,883
+844
+4% +$157K 0.41% 38
2025
Q1
$5.04M Buy
24,039
+912
+4% +$177K 0.5% 32
2024
Q4
$4.11M Buy
23,127
+415
+2% +$76.3K 0.42% 39
2024
Q3
$4.49M Sell
22,712
-22
-0.1% -$4.11K 0.45% 38
2024
Q2
$3.9M Sell
22,734
-399
-2% -$66.1K 0.41% 39
2024
Q1
$4.21M Sell
23,133
-377
-2% -$65K 0.45% 38
2023
Q4
$3.64M Buy
23,510
+341
+1% +$49.7K 0.42% 42
2023
Q3
$3.45M Buy
23,169
+966
+4% +$142K 0.44% 39
2023
Q2
$2.99M Sell
22,203
-1,297
-6% -$190K 0.36% 48
2023
Q1
$3.75M Buy
23,500
+89
+0.4% +$13.6K 0.48% 33
2022
Q4
$3.78M Buy
23,411
+923
+4% +$142K 0.52% 32
2022
Q3
$3.02M Sell
22,488
-1,053
-4% -$151K 0.47% 36
2022
Q2
$3.61M Sell
23,541
-1,848
-7% -$282K 0.52% 34
2022
Q1
$4.12M Buy
25,389
+538
+2% +$78.2K 0.52% 31
2021
Q4
$3.36M Buy
24,851
+514
+2% +$60.7K 0.4% 42
2021
Q3
$2.63M Sell
24,337
-404
-2% -$46.2K 0.35% 50
2021
Q2
$2.79M Buy
24,741
+955
+4% +$108K 0.38% 47
2021
Q1
$2.57M Buy
23,786
+589
+3% +$63K 0.37% 49
2020
Q4
$2.49M Sell
23,197
-1,200
-5% -$115K 0.38% 50
2020
Q3
$2.14M Buy
24,397
+1,891
+8% +$178K 0.38% 53
2020
Q2
$2.21M Buy
22,506
+2,352
+12% +$207K 0.44% 47
2020
Q1
$1.54M Buy
20,154
+3,463
+21% +$295K 0.43% 55
2019
Q4
$1.48M Buy
16,691
+1,392
+9% +$116K 0.34% 70
2019
Q3
$1.16M Sell
15,299
-2,149
-12% -$147K 0.29% 84
2019
Q2
$1.27M Buy
17,448
+793
+5% +$62.3K 0.31% 78
2019
Q1
$1.34M Sell
16,655
-3,212
-16% -$263K 0.34% 65
2018
Q4
$1.83M Buy
19,867
+4,278
+27% +$376K 0.53% 35
2018
Q3
$1.47M Buy
15,589
+1,180
+8% +$112K 0.37% 59
2018
Q2
$1.33M Sell
14,409
-1,189
-8% -$116K 0.37% 62
2018
Q1
$1.48M Buy
15,598
+197
+1% +$21.6K 0.43% 48
2017
Q4
$1.49M Sell
15,401
-854
-5% -$80.5K 0.44% 53
2017
Q3
$1.45M Buy
16,255
+578
+4% +$44K 0.47% 48
2017
Q2
$1.14M Sell
15,677
-337
-2% -$22.7K 0.39% 64
2017
Q1
$1.04M Sell
16,014
-251
-2% -$15.8K 0.37% 67
2016
Q4
$1.02M Buy
16,265
+514
+3% +$31.4K 0.39% 66
2016
Q3
$994K Buy
15,751
+165
+1% +$10.7K 0.4% 68
2016
Q2
$965K Buy
15,586
+1,599
+11% +$97.4K 0.39% 70
2016
Q1
$799K Sell
13,987
-7,884
-36% -$439K 0.29% 117
2015
Q4
$1.3M Sell
21,871
-1,681
-7% -$96.8K 0.49% 69
2015
Q3
$1.28M Buy
23,552
+6,893
+41% +$449K 0.49% 68
2015
Q2
$1.12M Buy
16,659
+1,057
+7% +$69K 0.39% 81
2015
Q1
$913K Buy
15,602
+4,732
+44% +$286K 0.32% 98
2014
Q4
$712K Buy
10,870
+543
+5% +$34.2K 0.26% 113
2014
Q3
$597K Sell
10,327
-469
-4% -$26K 0.23% 132
2014
Q2
$610K Sell
10,796
-194
-2% -$10.2K 0.23% 137
2014
Q1
$565K Sell
10,990
-2,685
-20% -$136K 0.23% 136
2013
Q4
$722K Buy
13,675
+174
+1% +$8.55K 0.31% 98
2013
Q3
$604K Buy
13,501
+709
+6% +$31.4K 0.29% 109
2013
Q2
$529K Buy
+12,792
New +$559K 0.23% 151

Other funds holding ABBV

Intrust Bank's ABBV Position: Q1 2026 in Review

Intrust Bank increased its AbbVie (ABBV) stake by 4.1% in Q1 2026, buying an estimated $235K and bringing the position to 26,626 shares worth $5.79M. The position accounts for 0.47% of the portfolio, ranked #33.

Intrust Bank first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.89M in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Intrust Bank held 26,626 shares of AbbVie worth $5.79M as of Q1 2026.
  • Intrust Bank bought 1,059 AbbVie shares in Q1 2026, an estimated $235K.
  • AbbVie made up 0.47% of Intrust Bank's portfolio in Q1 2026, its #33 holding.
  • Intrust Bank first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Intrust Bank's AbbVie position peaked at $5.89M in Q3 2025.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Intrust Bank's 13F filing for Q1 2026, filed 6 May 2026.